LARIMAR THERAPEUTICS, INC. (LRMR) Operating income 2016–2025
LARIMAR THERAPEUTICS, INC. (LRMR) annual operating income history from SEC filings — each fiscal year as reported.
-$172.5MFY2025 · since FY2016: -$58.2M → -$172.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$172.5M | -89.8% |
| FY2024 | -$90.9M | -117.7% |
| FY2023 | -$41.8M | -14.3% |
| FY2022 | -$36.5M | +27.6% |
| FY2021 | -$50.5M | -17.9% |
| FY2020 | -$42.8M | -84.4% |
| FY2019 | -$23.2M | +62.0% |
| FY2018 | -$61.1M | -15.3% |
| FY2017 | -$53.0M | +9.0% |
| FY2016 | -$58.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LRMR financial trends
LRMR RevenueLRMR Net incomeLRMR Net marginLRMR Gross profitLRMR Gross marginLRMR Operating marginLRMR Operating cash flowLRMR Free cash flowLRMR Capital expendituresLRMR Return on equityLRMR Stock buybacksLRMR Dividends paidLRMR Total assetsLRMR Total liabilitiesLRMR Shareholders’ equityLRMR overview →